montirelin

Known as: methyl(6)-oxothiomorpholinyl(5)-carbonyl-His(3)-ProNH2, 6-methyl-5-oxothiomorpholinyl-3-carbonylhistidyl prolinamide, Me(6)-oxothiomorpholinyl(5)-carbonylhistidyl(3)-prolinamide 
 

Topic mentions per year

Topic mentions per year

1995-2009
051019952009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
TRH (thyroliberin) and its analogues were reported to possess neuroprotective effects in cellular and animal experimental models… (More)
Is this relevant?
2009
2009
The histaminergic tuberomamillary nucleus (TMN) controls arousal and attention, and the firing of TMN neurons is state-dependent… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
The present study was undertaken to characterize the transport of (3-methyl-His(2)) thyrotropin-releasing hormone ([(3)H]MeTRH… (More)
Is this relevant?
1996
1996
Central effects of montirelin hydrate (NS-3) were electroencephalographically investigated in cats with experimentally induced… (More)
Is this relevant?
1995
1995
A study of fertility and early embryonic development to implantation of montirelin hydrate (NS-3), a new drug for the treatment… (More)
Is this relevant?
1995
1995
Montirelin hydrate (NS-3), a new drug for the treatment of disturbance of consciousness, was examined for mutagenicity in the… (More)
Is this relevant?
1995
1995
An antigenicity study of montirelin hydrate (NS-3), a new drug for the treatment of disturbance of consciousness, was conducted… (More)
Is this relevant?
1995
1995
A vascular irritability study of montirelin hydrate (NS-3) injection, a new drug for the treatment of disturbance of… (More)
Is this relevant?
1995
1995
The single dose toxicity studies of montirelin hydrate (NS-3), a new drug for the treatment of disturbance of consciousness, were… (More)
Is this relevant?
1995
1995
A repeated dose toxicity study of montirelin hydrate (NS-3), a new drug for the treatment of disturbance of consciousness, was… (More)
Is this relevant?